However, existing reports have shown their role in adjacent cancer studies: LRIG2 predicts poor prognosis of uterine cervix carcinoma [71], mutations in MSH2 are associated with Lynch syndrome [72, 73], and TMPO is widely overexpressed in digestive tract and lung cancers [74, 75]. Here, MSH2 is linked to cancer.